With a long established history of HIV s100 Prescriber Case Study groups delivered by VHHITAL and the Alfred Health team, ASHM is now working in collaboration with Bayside Health (formerly Alfred Health) to co-host this session, with an additional series set to launch in 2027.
This discussion group will give clinicians the opportunity to discuss cases and integrate the latest evidence into diagnosis and management strategies in their practice. Through peer discussion and expert facilitation, participants will explore complex treatment decisions, including antiretroviral therapy selection, medication interactions, adverse effects, and the application of current HIV clinical guidelines.
A portal will be made available to submit deidentified cases for discussion. All Victorian prescribers will be notified via email when the portal is open.
Please note this course is for s100 Prescribers practicing in Victoria only. Prescriber status and location of practice will be verified before registration is confirmed.
Please note: We cannot guarantee you will receive a zoom link if you have registered for this series after 4pm on the day before the session. If you find that you have not received a link, you can email us at [email protected].
Date, Time & Platform:
- Date: Thursday, 22 October 2026
- Time: 6:30pm – 8:00pm (AEDT)
- Platform: Live Online – Zoom
Learning Objectives:
Following participation in this case discussion group, participants will be able to:
- Identify concerns and formulate a management plan for antiretroviral therapy involving HIV treatment and s100 antiretroviral therapies using current evidence and clinical guidelines.
- Identify adverse effects, drug-drug interactions, and medication-related problems associated with HIV therapies and co-prescribed medicines.
- Describe patient-centred treatment plans that consider a range of factors such as individual circumstances, comorbidities, ageing, adherence, and patient preferences in people living with HIV.
- Reflect on HIV prescribing practice and your approach to comorbidity monitoring, cancer screening and prevention to improve the quality, safety and effectiveness of care for people living with HIV, along with patient experience.
- Reflect on personal and systemic factors that may contribute to stigma and discrimination in HIV care and identify barriers and enablers in your practice along with opportunities to improve clinical practice.
CPD and Endorsement:
This is an approved activity under the RACGP CPD Program. Activity number 1709842
- 1 Educational Hours
- 0.5 Performance Review Hours
This session is eligible for 2 HIV Prescriber Points for full attendance.
Supporters:
The HIV s100 Prescriber Case Discussion is supported by the Victorian Government and is delivered in collaboration with Bayside Health (formerly Alfred Health).
